CAMBRIDGE, Mass., Feb. 22 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., today announced that it will report its financial results for the fourth quarter and year-end 2005 on Thursday, March 2, 2006 before the U.S. financial markets open.
In conjunction with the issuance of the press release, management will host a conference call at 8:30 a.m. ET on Thursday, March 2, 2006 to discuss the company’s financial results for the fourth quarter and year-end 2005, clinical programs, financial guidance and milestones.
To access the call please dial (800) 774-5358 US/Canada or (706) 643-0743 International and enter passcode 5568948 or to listen to a live audio webcast of the call, go to “Calendar of Events” in the Idenix Investor Center at http://www.idenix.com. A replay of the call will also be available from 12:00 p.m. ET on March 2, 2006 until 12:00 p.m. ET on March 16, 2006. To access the replay, please dial 800-642-1687 or 706-645-9291 (international), and provide the access code 5568948. An archived webcast will also be available on the Idenix website for two weeks after the call.
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus. Idenix’s headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy. For more information on Idenix, please visit http://www.idenix.com.
Contact: Idenix Pharmaceuticals, Inc. Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals, Inc.
CONTACT: Media: Teri Dahlman, +1-617-995-9905, or Investors: Amy Sullivan,+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
